Fidson Healthcare Plc (NGX:FIDSON)

Market Cap	44.64B
Revenue (ttm)	84.19B
Net Income (ttm)	5.05B
Shares Out	2.29B
EPS (ttm)	2.20
PE Ratio	8.84
Forward PE	n/a
Dividend	1.00 (5.26%)
Ex-Dividend Date	Jun 19, 2024

Volume	153,827
Average Volume	426,402
Open	n/a
Previous Close	18.05
Day's Range	n/a
52-Week Range	12.40 - 20.90
Beta	0.23
RSI	60.46
Earnings Date	Mar 28, 2025

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is based in Lagos,...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 650
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: FIDSON

Financial Performance

In 2024, Fidson Healthcare's revenue was 84.19 billion, an increase of 58.70% compared to the previous year's 53.05 billion. Earnings were 5.05 billion, an increase of 39.91%.